Annual Users' Meeting
We invite you for a morning of learning about the latest in -omics, bioanalysis, environmental, food safety, clinical research and forensic toxicology. See how innovative Thermo Scientific™ technology is used by industry leaders to solve some of today's toughest analytical challenges.
When
Sunday, June 9
7 - 8 a.m., Check-in & Breakfast
8 a.m. - 12:15 p.m., Users' Meeting
Registration Closed
Where
Minneapolis Convention Center
1301 Second Avenue South
Minneapolis, MN 55403
Room: Ballroom A & B
Session and Tracks
Plenary Session Omics Pharma Environmental, Food & Clinical Research Plenary Session Omics Track Pharma Track Environmental, Food & Clinical TrackPlenary Speakers
Join us in welcoming our plenary speaker, Alexander Makarov, Ph.D., distinguished physicist and lead scientist of Thermo Scientific™ Orbitrap™ technology and Nevan Krogan, Ph.D., Professor at University of California-San Francisco and Associate Investigator at the J. David Gladstone Institutes.
Alexander Makarov, Ph.D. |
Nevan Krogan, Ph.D. |
Alexander Makarov, Ph.D
In 1996, Alexander joined HD Technologies, a small high-tech company that was formed by Steve Davis and Andy Hofmann and located in Manchester, UK. Although the company specialized in contract development of TOFMS systems, Alexander started to deviate from this technology and made his first steps towards the concept of the Orbitrap mass analyzer. Alexander's proof-of-principle results were presented at the ASMS Conference and the term "Orbitrap analyzer" was used for the first time in 1999.
Nevan Krogan, Ph.D.
Dr. Krogan is a leader in the field of systems biology. His lab develops and utilizes tools for the systematic interrogation of various biological systems, including model organisms like budding yeast and E. coli, as well as mouse and human cells. His group primarily focuses on generating and analyzing protein-protein and genetic interaction data as well as post-translationational modifications. More recently, the group has been using these systems methodologies to study host-pathogen relationships.
Back to the topPlenary Session
Register Now8 - 8:15 a.m. |
IntroductionKen Miller, Life Sciences Mass Spectrometry, Thermo Fisher Scientific |
8:15 - 8:50 a.m. |
Transforming Your Science: Fundamental Advances in LC/MSAlexander Makarov, Ph.D., Thermo Fisher Scientific |
8:50 - 9:25 a.m. |
From Systems to Mechanism: Deriving Functional Insights From Proteomic ApproachesNevan Krogan, Ph.D., Cellular & Molecular Pharmacology, UCSF School of Medicine |
Proteomics, Metabolomics & Lipidomics Track
Register Now9:40 - 9:55 a.m. |
IntroductionJulian Saba, Ph.D., Thermo Fisher Scientific |
9:55 - 10:20 a.m. |
From Noise to Signal: Proteome-Wide Multiplexed Quantitation using the MultiNotch MS3 Method Attains a New Level of Sensitivity, Precision and AccuracyGraeme McAlister, Ph.D., Dept. Cell Biology, Harvard Medical School |
10:20 - 10:45 a.m. |
Intervention: Overcoming your Dependence on Data Dependant AcquisitionMichael MacCoss, Ph.D., University of Washington School of Medicine |
10:45 - 11:10 a.m. |
Structure Activity Relationships of Nuclear Receptor, GPCR and Kinase Modulators Revealed with Differential HDXPatrick R. Griffin, Ph.D., Dept. Molecular Therapeutics, The Scripps Research Institute |
11:10 - 11:25 a.m. |
Coffee Break |
11:25 - 11:50 a.m. |
Metabolic Profiling of Human Disease and Model SystemsClary Clish, Ph.D., Broad Institute of MIT and Harvard |
11:50 a.m. - 12:15 p.m. |
Comprehensive Lipidome Profiling by Ultrahigh Resolution ESI-MS and MS/MS to Identify Biomarkers of Diabetic RetinopathyGavin E. Reid, Ph.D., Biochemistry and Molecular Biology, Michigan State University |
Pharma & Biopharmaceuticals Track
Register Now9:40 - 9:55 a.m. |
IntroductionPatrick Bennett, Thermo Fisher Scientific |
9:55 - 10:20 a.m. |
HRMS Bioanalysis of Micro Samples Employing Membrane-Based Dried Matrix Spots: An Alternative to Cellulose DBS SubstratesRob Sturm, Ph.D., Quintiles |
10:20 - 10:45 a.m. |
Creation of Rich MSn Data for Structure Elucidation in Quan/Qual Analysis: Applications of Combined HCD/CID and New Isolation TechniquesJonathan Josephs, Ph.D, Principal Scientist, Bristol-Myers Squibb |
10:45 - 11:10 a.m. |
The Main Cause of Amino Acid Misincorporations in Recombinant ProteinsZhongqi Zhang, Scientific Director, Amgen |
11:10 - 11:25 a.m. |
Coffee Break |
11:25 - 11:50 a.m. |
Exploring Latest Innovations in Orbitrap Technology for In-Depth Characterization of Recombinant ProteinsMelissa Alvarez, Senior Research Associate, Genentech |
11:50 a.m. - 12:15 p.m. |
Leveraging the Intrinsic Properties of CESI-MS (Capillary Electrophoresis-Electrospray Ionization- MS) for Achieving Highly Informative Peptide Mapping of Monoclonal AntibodiesJean-Marc Busnel, Ph.D., Beckman Coulter |
Environmental Analysis, Food Safety & Clinical Research Track
Register Now9:40 - 9:55 a.m. |
IntroductionDipankar Ghosh, Ph.D., Thermo Fisher Scientific |
9:55 - 10:20 a.m. | Implementation of the Prelude SPLC System in the Clinical Research Laboratory: A Users PerspectiveRoy Peake, Ph.D., Dept. Clinical Chemistry, Boston Children’s Hospital |
10:20 - 10:45 a.m. |
Paperspray – A Revolution in High Throughput Blood Spot AnalysisNick Manicke, Ph.D, Chemistry Department, Purdue University |
10:45 - 11:10 a.m. |
Advances in Triple Quad MS Technology and the Impact on Clinical ResearchMarta Kozak, Thermo Fisher Scientific |
11:10 - 11:25 a.m. |
Coffee Break |
11:25 - 11:50 a.m. |
Multi Antibiotic Residue Detection - Status Quo and Challenges for Confirmatory and Screening ApproachesScarlett Biselli, Ph.D., Eurofins, Hamburg |
11:50 a.m. - 12:15 p.m. |
LC-Orbitrap Based Qualitative, Quantitative, and Standard-less Analysis of Environmental Pollutants of Emerging ConcernPaul Yang, Ph.D., Ontario Ministry of the Environment, Canada |